人工耳蜗植入后耳蜗健康监测揭示听力结局的生物标志物
这项前瞻性临床队列研究纳入32例人工耳蜗植入者,利用患者居家自测的耳蜗电图和四点阻抗监测术后3个月内的波动。结果显示,植入时实时ECochG标志与较差的听力保留和较高阻抗相关,居家监测发现的耳蜗微音电位振幅下降也与较差的听力保留和较高阻抗相关。结论认为患者启动的居家监测可行,CM振幅和4PI有潜力用于个性化术后管理。
要点
- 植入时实时ECochG标志可预测较差的听力保留和术后较高阻抗。
- 居家监测的CM振幅下降与听力保留变差和阻抗升高相关。
- 患者居家监测耳蜗健康生物标志物在术后3个月内可行。
核心结论
- 患者启动的居家耳蜗健康生物标志物监测可行,为了解CI后内耳功能恢复提供有价值信息。
- CM振幅和4PI等标志物有潜力用于个性化术后管理并改善听力保留结局。
研究设计与样本
- 前瞻性临床队列研究,利用患者居家自测的耳蜗电图和四点阻抗监测术后前3个月的波动。
- 研究纳入32例完成术后前3个月居家测试的受试者。
主要发现
- 植入时实时ECochG监测中识别的标志与较差的听力保留结局相关(Skarzynski听力保留评分:平均听力保留56.88% vs 38.91%,p=0.0328)。
- 植入时实时ECochG标志与居家测试记录的较高阻抗相关(峰值中位4PI:398.46 Ω vs 270.75 Ω,p=0.0478)。
- 居家监测检测到的CM振幅下降与较差的听力保留相关(平均LFPTM损失:31.45 dB vs 11.78 dB,p=0.0003)。
- 居家监测检测到的CM振幅下降与较高阻抗值相关(431.3 Ω vs 262.9 Ω,p=0.0047)。
临床怎么用
- 可考虑在CI术后前3个月采用患者居家监测ECochG和4PI来追踪内耳功能恢复。
- 关注植入时实时ECochG标志和术后CM振幅下降,以识别听力保留较差的高风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aims to elucidate the timing and mechanisms associated with postoperative residual hearing loss following cochlear implantation and to assess the feasibility of clinical tools designed for prospective cochlear health monitoring. DESIGN: A prospective clinical cohort investigation was conducted utilizing patient-administered in-home cochlear health monitoring to track electrocochleography (ECochG) and four-point impedance (4PI) fluctuations during the first three postoperative months. RESULTS: The study included 32 subjects who completed the in-home testing over the first 3 months following cochlear implantation. ECochG markers identified during real-time ECochG monitoring of electrode insertion correlated with poorer hearing preservation outcomes (Skarzynski hearing preservation scores [mean hearing preservation: 56.88 versus 38.91%, p = 0.0328]) and higher impedances recorded on in-home testing (peak median 4PI: 398.46 Ω versus 270.75 Ω, p = 0.0478). Drops in cochlear microphonic (CM) amplitude detected through in-home monitoring were associated with poorer hearing preservation (mean LFPTM loss: 31.45 versus 11.78 dB, p = 0.0003) and higher impedance values (431.3 Ω versus 262.9 Ω, p = 0.0047). The study identified significant markers of hearing preservation in CM amplitude and 4PI, detectable through postoperative in-home monitoring. CONCLUSIONS: Patient-initiated in-home monitoring of cochlear health biomarkers is feasible and provides valuable insights into the recovery of inner ear function following CI. The identified markers, CM amplitude, and 4PI have the potential to personalize postoperative care and improve hearing preservation outcomes.
引用
- Shute WG, Collins AM, Bester C, et al. Cochlear Health Monitoring Post-Cochlear Implantation Reveals Biomarkers for Hearing Outcomes. Ear Hear. 2026. PMID: 42501298. doi:10.1097/AUD.0000000000001866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。